Megasoft has announced the proposed sale of its entire 36.52% holding in Extrovis AG, Switzerland, to Refex Life Sciences for $15 million.
Megasoft has announced the proposed sale of its entire 36.52% holding in Extrovis AG, Switzerland, to Refex Life Sciences for $15 million.